Top-News

Avanos Medical Aktie News

Aktie
WKN:  A2JNRG ISIN:  US05350V1061 US-Symbol:  AVNS Branche:  Gesundheitswesen: Ausstattung u. Produkte Land:  USA
11,26 $
+0,13 $
+1,17%
9,6626 € 05.12.25
Depot/Watchlist
Marktkapitalisierung *
-
Streubesitz
4,31%
KGV
-1,87
Index-Zuordnung
-

Avanos Medical News

05.11.25 - PR Newswire
Avanos Medical, Inc. Announces Third Quarter 2025 Results
Avanos Medical, Inc. Announces Third Quarter 2025 Results PR Newswire
27.10.25 - PR Newswire
Avanos Medical, Inc. to Webcast Conference Call Discussing Third Quarter 2025 Financial Results
Avanos Medical, Inc. to Webcast Conference Call Discussing Third Quarter 2025 Financial Results PR Newswire
23.10.25 - PR Newswire
WRS Group Announces Agreement to Acquire Avanos Medical's US Game Ready® Orthopedic Rental Business
WRS Group Announces Agreement to Acquire Avanos Medical's US Game Ready® Orthopedic Rental Business PR Newswire
15.09.25 - PR Newswire
Avanos Medical Acquires Nexus Medical to Strengthen Nutrition and Medication Delivery in Critical Care
Avanos Medical Acquires Nexus Medical to Strengthen Nutrition and Medication Delivery in Critical Care PR Newswire
05.08.25 - PR Newswire
Avanos Medical Announces Appointment of Scott Galovan as Senior Vice President, Chief Financial Officer; David Pacitti Appointed to Board of Directors
Avanos Medical Announces Appointment of Scott Galovan as Senior Vice President, Chief Financial Officer; David Pacitti Appointed to Board of Directors PR Newswire
05.08.25 - PR Newswire
Avanos Medical, Inc. Announces Second Quarter 2025 Results
Avanos Medical, Inc. Announces Second Quarter 2025 Results PR Newswire
31.07.25 - PR Newswire
Avanos Announces Divestiture of Hyaluronic Acid Product Line to Channel-Markers Medical
Avanos Announces Divestiture of Hyaluronic Acid Product Line to Channel-​Markers Medical PR Newswire
24.07.25 - PR Newswire
Avanos Medical, Inc. to Webcast Conference Call Discussing Second Quarter 2025 Financial Results
Avanos Medical, Inc. to Webcast Conference Call Discussing Second Quarter 2025 Financial Results PR Newswire
09.06.25 - PR Newswire
Avanos Medical, Inc. Welcomes Camille Chang Gilmore as Senior Vice President and Chief Human Resources Officer
Avanos Medical, Inc. Welcomes Camille Chang Gilmore as Senior Vice President and Chief Human Resources Officer PR Newswire
06.05.25 - PR Newswire
Avanos Medical, Inc. Announces First Quarter 2025 Results
Avanos Medical, Inc. Announces First Quarter 2025 Results PR Newswire
28.04.25 - PR Newswire
Avanos Medical, Inc. to Webcast Conference Call Discussing First Quarter 2025 Financial Results
Avanos Medical, Inc. to Webcast Conference Call Discussing First Quarter 2025 Financial Results PR Newswire
02.04.25 - PR Newswire
Avanos Expands Direct Operations for MIC-KEY* Enteral Feeding Products in the UK starting July 2025
Avanos Expands Direct Operations for MIC-KEY* Enteral Feeding Products in the UK starting July 2025 PR Newswire
02.04.25 - PR Newswire
Avanos Expands Direct Operations for MIC-KEY* Enteral Feeding Products in the UK starting July 2025
Avanos Expands Direct Operations for MIC-KEY* Enteral Feeding Products in the UK starting July 2025 PR Newswire
17.03.25 - PR Newswire
Avanos Medical Announces Appointment of David Pacitti as Chief Executive Officer
Avanos Medical Announces Appointment of David Pacitti as Chief Executive Officer PR Newswire
26.02.25 - PR Newswire
Avanos Medical, Inc. Announces Fourth Quarter and Full-Year 2024 Results
Avanos Medical, Inc. Announces Fourth Quarter and Full-Year 2024 Results PR Newswire
19.02.25 - PR Newswire
Avanos Medical, Inc. to Webcast Conference Call Discussing Fourth Quarter and Full Year 2024 Financial Results
Avanos Medical, Inc. to Webcast Conference Call Discussing Fourth Quarter and Full Year 2024 Financial Results PR Newswire
06.01.25 - PR Newswire
Avanos Medical, Inc. to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Avanos Medical, Inc. to Present at the 43rd Annual J.P. Morgan Healthcare Conference PR Newswire

Newssuche

Videos

newspaper
06.12.25
Master the Trading!
In diesem Trading-​Webinar haben wir von A bis Z den Aufbau professionellen Tradings thematisiert und ... Mehr »
Anzeige

Aktie im Fokus

Breaking News
TempraMed Technologies Ltd
0,3605 €
-20,7%
TempraMed Technologies Ltd Chart
Das 1.000% Wachstum initiiert?!
Mehr zur Aktie »